Patents by Inventor Michel Ducreux

Michel Ducreux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PREDICTING EFFICACY OF DRUGS IN A PATIENT
    Publication number: 20190005190
    Abstract: The present invention concerns a method for predicting the relative efficacy of a plurality of drugs for treating a tumour in an individual comprising the molecular characterization of the tumour, and the calculation of a score for the plurality of drugs essentially based on the percentage of deregulated target genes.
    Type: Application
    Filed: September 10, 2018
    Publication date: January 3, 2019
    Inventors: VLADIMIR LAZAR, JEAN-CHARLES SORIA, MICHEL DUCREUX, THOMAS TURSZ
  • Computer implemented methods of treating lung cancer
    Patent number: 10095829
    Abstract: The present invention concerns a method for predicting the relative efficacy of a plurality of drugs for treating a tumor in an individual comprising the molecular characterization of the tumor, and the calculation of a score for the plurality of drugs essentially based on the percentage of deregulated target genes.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: October 9, 2018
    Assignee: WORLDWIDE INNOVATIVE NETWORK
    Inventors: Vladimir Lazar, Jean-Charles Soria, Michel Ducreux, Thomas Tursz
  • METHOD FOR PREDICTING EFFICACY OF DRUGS IN A PATIENT
    Publication number: 20120136583
    Abstract: The present invention concerns a method for predicting the relative efficacy of a plurality of drugs for treating a tumour in an individual comprising the molecular characterization of the tumour, and the calculation of a score for the plurality of drug essentially based on the percentage of deregulated target gene.
    Type: Application
    Filed: July 6, 2010
    Publication date: May 31, 2012
    Applicant: WORLDWIDE INNOVATIVE NETWORK
    Inventors: Vladimir Lazar, Jean-Charles Soria, Michel Ducreux, Thomas Tursz